vs
Side-by-side financial comparison of CareTrust REIT, Inc. (CTRE) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
CareTrust REIT, Inc. is the larger business by last-quarter revenue ($134.9M vs $75.5M, roughly 1.8× PUMA BIOTECHNOLOGY, INC.). On growth, CareTrust REIT, Inc. posted the faster year-over-year revenue change (55.1% vs 27.7%). Over the past eight quarters, CareTrust REIT, Inc.'s revenue compounded faster (46.2% CAGR vs 31.3%).
CareTrust REIT, Inc.CTREEarnings & Financial Report
Target Healthcare REIT is a British property investment company which invests in healthcare properties and holds a large portfolio of care homes. It is structured as a real estate investment trust (REIT) and is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
CTRE vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $134.9M | $75.5M |
| Net Profit | $111.3M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | — | 22.7% |
| Net Margin | 82.5% | — |
| Revenue YoY | 55.1% | 27.7% |
| Net Profit YoY | 113.5% | — |
| EPS (diluted) | $0.52 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $134.9M | $75.5M | ||
| Q3 25 | $132.4M | $54.5M | ||
| Q2 25 | $112.5M | $52.4M | ||
| Q1 25 | $96.6M | $46.0M | ||
| Q4 24 | $86.9M | $59.1M | ||
| Q3 24 | $77.4M | $80.5M | ||
| Q2 24 | $68.9M | $47.1M | ||
| Q1 24 | $63.1M | $43.8M |
| Q4 25 | $111.3M | — | ||
| Q3 25 | $74.9M | $8.8M | ||
| Q2 25 | $68.5M | $5.9M | ||
| Q1 25 | $65.8M | $3.0M | ||
| Q4 24 | $52.1M | — | ||
| Q3 24 | $33.4M | $20.3M | ||
| Q2 24 | $10.8M | $-4.5M | ||
| Q1 24 | $28.7M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
| Q4 25 | — | 22.7% | ||
| Q3 25 | 58.1% | 17.6% | ||
| Q2 25 | 61.3% | 12.7% | ||
| Q1 25 | — | 8.7% | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | 43.0% | 27.4% | ||
| Q2 24 | 15.1% | -4.6% | ||
| Q1 24 | — | -5.3% |
| Q4 25 | 82.5% | — | ||
| Q3 25 | 56.6% | 16.2% | ||
| Q2 25 | 60.9% | 11.2% | ||
| Q1 25 | 68.1% | 6.5% | ||
| Q4 24 | 60.0% | — | ||
| Q3 24 | 43.2% | 25.2% | ||
| Q2 24 | 15.6% | -9.6% | ||
| Q1 24 | 45.6% | -11.0% |
| Q4 25 | $0.52 | $0.26 | ||
| Q3 25 | $0.35 | $0.17 | ||
| Q2 25 | $0.35 | $0.12 | ||
| Q1 25 | $0.35 | $0.06 | ||
| Q4 24 | $0.30 | $0.40 | ||
| Q3 24 | $0.21 | $0.41 | ||
| Q2 24 | $0.07 | $-0.09 | ||
| Q1 24 | $0.22 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $198.0M | $97.5M |
| Total DebtLower is stronger | $894.2M | $22.7M |
| Stockholders' EquityBook value | $4.0B | $130.3M |
| Total Assets | $5.1B | $216.3M |
| Debt / EquityLower = less leverage | 0.22× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $198.0M | $97.5M | ||
| Q3 25 | $712.5M | $94.4M | ||
| Q2 25 | $306.1M | $96.0M | ||
| Q1 25 | $26.5M | $93.2M | ||
| Q4 24 | $213.8M | $101.0M | ||
| Q3 24 | $377.1M | $96.7M | ||
| Q2 24 | $495.1M | $96.8M | ||
| Q1 24 | $451.2M | $107.2M |
| Q4 25 | $894.2M | $22.7M | ||
| Q3 25 | $893.8M | $34.0M | ||
| Q2 25 | $1.2B | $45.3M | ||
| Q1 25 | $822.1M | $56.7M | ||
| Q4 24 | $396.9M | $68.0M | ||
| Q3 24 | $396.7M | $79.3M | ||
| Q2 24 | $671.1M | $90.7M | ||
| Q1 24 | $595.9M | $102.0M |
| Q4 25 | $4.0B | $130.3M | ||
| Q3 25 | $4.0B | $115.3M | ||
| Q2 25 | $3.3B | $104.7M | ||
| Q1 25 | $2.9B | $97.1M | ||
| Q4 24 | $2.9B | $92.1M | ||
| Q3 24 | $2.4B | $71.1M | ||
| Q2 24 | $1.9B | $48.5M | ||
| Q1 24 | $1.7B | $51.0M |
| Q4 25 | $5.1B | $216.3M | ||
| Q3 25 | $5.1B | $202.9M | ||
| Q2 25 | $4.7B | $194.9M | ||
| Q1 25 | $3.9B | $196.2M | ||
| Q4 24 | $3.4B | $213.3M | ||
| Q3 24 | $2.9B | $220.7M | ||
| Q2 24 | $2.7B | $205.0M | ||
| Q1 24 | $2.3B | $214.1M |
| Q4 25 | 0.22× | 0.17× | ||
| Q3 25 | 0.22× | 0.30× | ||
| Q2 25 | 0.35× | 0.43× | ||
| Q1 25 | 0.28× | 0.58× | ||
| Q4 24 | 0.14× | 0.74× | ||
| Q3 24 | 0.16× | 1.12× | ||
| Q2 24 | 0.35× | 1.87× | ||
| Q1 24 | 0.36× | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $394.0M | $14.4M |
| Free Cash FlowOCF − Capex | — | $14.4M |
| FCF MarginFCF / Revenue | — | 19.1% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | 3.54× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $394.0M | $14.4M | ||
| Q3 25 | $100.9M | $9.7M | ||
| Q2 25 | $100.8M | $14.1M | ||
| Q1 25 | $71.4M | $3.6M | ||
| Q4 24 | $244.3M | $15.6M | ||
| Q3 24 | $67.2M | $11.0M | ||
| Q2 24 | $53.0M | $1.0M | ||
| Q1 24 | $48.8M | $11.2M |
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | 3.54× | — | ||
| Q3 25 | 1.35× | 1.10× | ||
| Q2 25 | 1.47× | 2.41× | ||
| Q1 25 | 1.08× | 1.21× | ||
| Q4 24 | 4.68× | — | ||
| Q3 24 | 2.01× | 0.54× | ||
| Q2 24 | 4.92× | — | ||
| Q1 24 | 1.70× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
